Of the 10 companies that announced funding in the first half of the year, just four focus on traditional hardware. Others include biologics, artificial ligaments and software to support device customization.
Vallum received FDA 510(k) clearance to market a PEEK interbody fusion device with a PEEKplus® nanotextured surface created with proprietary Accelerated Neutral Atom Beam technology.
Five-year follow-up results demonstrate that Cartiva's Synthetic Cartilage Implant provided long-term durability in pain and functional improvements in the treatment of great toe arthritis.
Artoss completed a US $1MM funding round. Proceeds will support development of new NanoBone® bone graft products for the U.S. market, regulatory requirements and commercialization.